Chicago, IL -- (SBWire) -- 02/20/2017 --According to the new market research report, "Molecular Diagnostics Market, by Products (Instruments & Systems and Reagents & Consumables), Applications (Infectious Diseases, Blood Screening, Histology, Oncology, Prenatal, Coagulation, Tissue Typing, Inherited Diseases, Genetic Testing and Pharmacogenomics), Technologies (DNA Sequencing, PCR Microarray and Fluorescent In Situ Hybridization) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022", published by Scalar Market Research, the global molecular diagnostics market is expected to grow from USD 5.44 billion in 2014 and become worth USD 11.04 billion by 2022, growing at a CAGR of 9.3% from 2014 to 2022.
The global molecular diagnostics market report offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key players, premium trends and forecast to 2022. It also focuses on the key drivers and opportunities in this market.
Browse Report Summary: https://www.scalarmarketresearch.com/market-reports/molecular-diagnostics-market
Buyers can expect to receive 10% customization on this report.
Key findings of the report:
1. The rapidly advancing technology and the strong demand for personalized medicine are expected to be some of the major driving factors for the molecular diagnostics market.
2. Increasing instances of chronic diseases, growing awareness towards prevention and control of these diseases and the growth of the healthcare market across the emerging markets are some of the major driving factors as well.
3. According to the molecular diagnostics market report, the emerging markets are expected to create strong investment and growth opportunities for the key players in the market.
North America is projected to dominate the molecular diagnostics market
According to the report, the North America region is expected to hold the largest share in the global molecular diagnostics market during the forecast period. The strong awareness towards healthcare and the rising prevalence of the chronic diseases are some of the major contributing factors to the stronghold of the North America region over the global market. The report expects that Asia-Pacific will be the fastest-growing geographic region in the market during the forecast period.
Request Sample: https://www.scalarmarketresearch.com/request-sample.php?id=131
The key players highlighted in the molecular diagnostics market report include:
1. Abbott Laboratories
2. Becton, Dickinson and Company
3. Cepheid, Inc.
4. Grifols International, S.A.
5. Hologic, Inc.
6. QIAGEN, Inc.
7. F. Hoffmann-La Roche Ltd.
8. Siemens AG
Browse Related Reports:
Dermatology Devices Market, by Diagnostic Devices (Dermatoscopes, Microscopes, Imaging Techniques), Treatment Devices (Liposuction, Microdermabrasion, Cryotherapy, Electrosurgical, Light Therapy Devices, Lasers), Applications (Cancer Diagnosis, Wrinkle Removal, Skin Rejuvenation, Skin Resurfacing, Vascular Lesions, Acne, Psoriasis, Hair Removal) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022
https://www.scalarmarketresearch.com/market-reports/dermatology-devices-market
Prescription Pharmaceuticals Market, by Therapeutic Segments (Cardiovascular Disorders, Inflammatory Conditions, Metabolic Disorders, Oncology, Respiratory Disorders, Others), Formulations (Capsules, Inhalants, Parenterals, Tablets, Topicals) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2020
https://www.scalarmarketresearch.com/market-reports/prescription-pharmaceuticals-market
About Scalar Market Research
Scalar Market Research, Inc. is a Chicago, U.S.-based market research and consulting firm that serves Fortune 1000 companies, leading businesses and upcoming organizations from around the world to help them achieve their business goal of sustainable revenue growth, utilizing Scalar's premium market research reports and consulting services to make critical strategic decisions.
Our real-time industry data tracking, with the help of advanced analytics and machine learning, offers our clients highly accurate 360-degree perspective of key developments in niche markets. Our team of industry experts, with a thorough understanding of global markets and cumulative industry experience spanning 100+ years, work relentlessly to help our clients realize their most important business goals.
Find out more about our services at: http://www.scalarmarketresearch.com
Contact:
Moses Nakka
8770 W Bryn Mawr Ave.,
Suite 1300
Chicago, IL 60631
Tel.: +1-800-213-5170 (U.S./Canada Toll-free)
Email: sales@scalarmarketresearch.com
Follow us on LinkedIn: https://www.linkedin.com/company/scalar-market-research
Molecular Diagnostics Market Is Worth USD 5.44 Billion in 2014 and Is Expected to Reach USD 11.04 Billion by 2022, at a CAGR of 9.3% from 2014 to 2022
Growing prevalence of chronic diseases, the increased usage of the biomarkers, high demand for the personalized medicines, and the rapid technology advancements are the major drivers for the molecular diagnostics market.